-transparent.png){kind=logo}
Aromatic alpha-amino-alpha-methyl acids and alpha-hydrazino-alpha-methyl acids are known aromatic amino acid decarboxylase inhibitors. Specific derivatives such as 2-amino-2-methyl-3-(3,4- dihydroxyphenyl)propanoate, Aldomet, and 2-hydrazino-2-methyl-3-(3,4- dihydroxyphenyl)propanoate, Lodosyn, have been developed as therapeutic agents to treat hypertension and Parkinson's disease, respectively. We recently reported a method for the kinetic resolution of the racemic esters of such compounds using a crude preparation of a novel enzyme catalyst from the yeast Candida lipolytica (Yee, C.; Blythe, T.A., McNabb, T.J.; Walts, A.E. J. Org. Chem. 1992, 57, 3525-3527). Here we report the purification and initial characterization of the active enzyme component, an enzyme given the name Candida lipolytica ester hydrolase (CLEH). CLEH was purified to > 95% homogeneity by chromatography on Matrex Blue B resin. The enzyme was found to be a glycoprotein with M(r) = 80,000-300,000. In addition to esterolytic activity, the enzyme was found to catalyze the hydrolysis of amides, anilides and peptides. Sequence analysis of internal peptides of CLEH revealed striking homology to a number of enzymes belonging to the group of serine carboxypeptidases (E.C. 3.4.16.1). One peptide aligned with the canonical serine carboxypeptidase active site sequence, GESYAG. Based on the structural relationship of CLEH to serine carboxypeptidases, three representative serine carboxypeptidases were evaluated for their utility in resolving racemic alpha-tertiary ester substrates and compared with the activity of CLEH. All enzymes revealed similarly high activity and enantioselectivity towards the alpha-hydrazino-alpha-methyl ester precursor of the Parkinson-drug Carbidopa. However, differences in enantioselectivity were observed with other alpha-tertiary-substituted ester substrates. Serine carboxypeptidase-catalyzed ester resolutions thus offer a new route to many sterically hindered homochiral alpha-amino, alpha-hydrazino and alpha-hydroxy carboxylic acids.
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
February 2009,
Chemical & pharmaceutical bulletin,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
June 2004,
The Journal of organic chemistry,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
October 1975,
Research communications in chemical pathology and pharmacology,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
January 1982,
Methods in enzymology,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
April 2000,
Organic letters,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
July 2003,
Chemical communications (Cambridge, England),
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
May 2003,
Chirality,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
April 1974,
Archiv der Pharmazie,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
June 2016,
Journal of the American Chemical Society,
H K Kallwass, and
C Yee, and
T A Blythe, and
T J McNabb, and
E E Rogers, and
S L Shames
January 2007,
Luminescence : the journal of biological and chemical luminescence,
